|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States. |
| 公司地址
| 36 Dame Street, 8th Floor, One Central Plaza, Dublin, IRL, D02 K7K5 |
| 電話號碼
| +353 16699020 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.amarincorp.com |
| 員工數量
| 80 |
| Mr. Peter Fishman |
Senior Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 310.17K |
02/03/2026 |
| Dr. Steven B. Ketchum, PhD |
Executive Vice President, President, Research and Development and Chief Scientific Officer |
美元 667.15K |
10/04/2025 |
| Mr. Aaron D. Berg |
Director, President and Chief Executive Officer |
美元 662.60K |
02/03/2026 |
| Dr. David Paul Keenan, PhD |
Executive Vice President and Chief Operating Officer |
-- |
22/10/2025 |
| Mr. Jonathan N. Provoost |
Executive Vice President, Chief Legal and Compliance Officer and Secretary |
美元 465.00K |
10/04/2025 |
|
|
| Ms. Patrice Bonfiglio |
Independent Director |
02/03/2026 |
| Mr. Keith L. Horn |
Independent Director |
02/03/2026 |
| Mr. Oliver O'Connor |
Independent Director |
02/03/2026 |
| Mr. Aaron D. Berg |
Director, President and Chief Executive Officer |
02/03/2026 |
| Dr. Odysseas D. Kostas, M.D. |
Chairman of the Board |
02/03/2026 |
| Mr. Michael Torok |
Director |
02/03/2026 |
| Mr. Louis Sterling, III |
Independent Director |
02/03/2026 |
| Ms. Diane E. Sullivan |
Independent Director |
02/03/2026 |
| Dr. Paul Cohen, M.D. |
Independent Director |
02/03/2026 |
|
|
|
|
